Centre Hospitalier Sud Francilien
Corbeil-Essonnes, 91106, France
NCT Number: NCT06336577
The purpose of this study is to describe infectious and non-infectious lower respiratory tract diseases in children with Down syndrome followed in pediatric pulmonology consultations in Ile de France.
Looking for future studies?
Notify Me1 day–17 year
All sexes
Observational
Corbeil-Essonnes, 91106, France
Down syndrome is the most common chromosomal abnormality, affecting 600 to 800 births per year. It results in a clinical picture that combines developmental delay, mental deficiency, facial dysmorphism and visceral malformations.
Optimal medical care of Down syndrome patients requires a good knowledge of the different systems affected by the disease, particularly respiratory damage.
Numerous articles have been published describing upper respiratory problems in children with Down syndrome. On the other hand, lower respiratory problems causing significant morbidity and mortality remain underestimated and poorly understood in this population.
The objective of this study is to describe lower respiratory problems in patients with T21, in order to improve their management.
This study will also make it possible to describe more precisely the impact that these attacks have on Down syndrome patients.
This study also describe the associated extra-respiratory disorders to improve overall care Finally, the respiratory care of these patients will be described, with the aim of standardizing practices.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
lower respiratory tract disease
Time frame: at day 0
number
Centre Hospitalier Sud Francilien
Other
Acronym: ARBT21
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02421276
Abnormalities, Multiple, Autoimmune Diseases
Denver, Colorado, United States
View Trial DetailsNCT07702201
Abnormalities, Multiple, Chromosome Disorders
Giza, Eldoky, Egypt
View Trial DetailsNCT05662228
Abnormalities, Multiple, Autoimmune Diseases
Los Angeles, California, United States
View Trial DetailsNCT06592404
Abnormalities, Multiple, Autism Spectrum Disorder
Sittard, Limburg, Netherlands
View Trial Details